Fennec Pharmaceuticals Inc.
FENC
$11.29
-$0.06-0.53%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.97M | 201.00K | -4.79M | -637.00K | -3.15M |
| Total Depreciation and Amortization | 25.00K | 26.00K | -77.00K | 26.00K | 25.00K |
| Total Amortization of Deferred Charges | -- | -- | 27.00K | 12.00K | 13.00K |
| Total Other Non-Cash Items | 1.49M | 937.00K | 7.97M | 547.00K | 2.64M |
| Change in Net Operating Assets | -3.44M | 1.22M | -9.10M | 1.55M | -3.21M |
| Cash from Operations | 50.00K | 2.38M | -5.96M | 1.49M | -3.69M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -19.48M | -- | -- |
| Issuance of Common Stock | 1.96M | 1.32M | 42.25M | 1.80M | -- |
| Repurchase of Common Stock | -941.00K | -311.00K | -26.00K | -50.00K | -284.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1.95M | -- | -- |
| Cash from Financing | 1.02M | 1.01M | 20.80M | 1.75M | -284.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.07M | 3.39M | 14.84M | 3.24M | -3.97M |